Sunesis Pharmaceuticals - Inspired to Make a Difference in Cancer Patients Lives.

Presentations - Investigator Sponsored Trials

Download a presentation for more information.
Adobe® Reader®

Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of Acute Myeloid Leukemia (VITAL) Patients Eligible FOR Intensive Chemotherapy: A Planned Interim Analysis
59th ASH Annual Meeting & Exposition
Atlanta, Georgia
Sunday, December 10, 2017
Download (PDF,126KB)
Vosaroxin Plus Azacitidine Treatment for Patients With Myelodysplastic Syndrome (MDS):
A Phase 1/Cohort Expansion Study
22nd Congress of the European Hematology Association
Madrid, Spain
Friday, June 23, 2017
Download (PDF,126KB)
Anti-leukemic effects of vosaroxin, an anti-cancer quinolone derivative, on hypomethylating agent resistant cells
The 57th Spring Meeting of the Korean Society of Hematology
Seoul, Korea
Saturday, May 27, 2017
Download (PDF,654KB)
Phase I/II study of vosaroxin and decitabine in newly diagnosed older patients (PTS) with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
European Hematology Association Annual Congress
Copenhagen, Denmark
Saturday, June 11, 2016
Download (PDF,152KB)
Phase I/II Study of Vosaroxin and Decitabine in Newly Diagnosed Older Patients (pts) with Acute Myeloid Leukemia (AML) and High Risk Myelodyplastic Syndrome (MDS)
57th American Society of Hematology Annual Meeting
Orlando, FL
December 7, 2015
Download (PDF,KB)
A Phase I Study of Vosaroxin Plus Azacitidine for Patients with Myelodysplastic Syndrome
57th American Society of Hematology Annual Meeting
Orlando, FL
December 5, 2015
Download (PDF,276KB)
Phase I/II Study of Vosaroxin and Decitabine in Newly Diagnosed Older Patients with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
56th American Society of Hematology Annual Meeting
San Francisco, CA
December 8, 2014
Download (PDF,389KB)
Phase I/II Study of Vosaroxin and Decitabine in Newly Diagnosed Older Patients (pts) with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
American Society of Clinical Oncology 2014 Annual Meeting
Chicago, Illinois
June 2nd, 2014
Download (PDF,537KB)
Phase I/II Study of Vosaroxin and Decitabine in Older Patients (pts) with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
American Association of Cancer Research Annual Meeting 2014
San Diego, California
April 8th, 2014
Download (PDF,269KB)